Results 151 to 160 of about 50,247 (212)

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences

open access: yesVaccines
Background: Polypeptide vaccines have the potential to improve immune responses by targeting conserved and weakly immunogenic regions in antigens. This study aimed to identify and evaluate the efficacy of a novel influenza universal vaccine candidate ...
Song Zhao   +7 more
doaj   +1 more source

The Search for a Universal Influenza Vaccine: Possibilities and Limitations

open access: yesEpidemiology and Vaccinal Prevention, 2019
Relevance.Upon the unquestionable utility of regular season vaccination influenza vaccine effectiveness varies depending on how vaccinal strains to be in accord with seasonal circulating influenza strains, i.e. the influenza vaccines are virtually strain-spesific and not able to elicit broad, protective immune responses.
openaire   +3 more sources

Intellectual Property Management Strategies to Accelerate the Development and Access of Vaccines and Diagnostics: Case Studies on Pandemic Influenza, Malaria and SARS [PDF]

open access: yes, 2006
Achieving global access to vaccines, diagnostics, and pharmaceuticals remains a challenge. Throughout the developing world, intellectual property (IP) constraints complicate access to critically essential medical technologies and products.
Eiss, Robert   +3 more
core   +1 more source

Vaccination Hesitation: Investigation Why Parents Decline Pediatric Influenza Vaccines in Juneau, Alaska [PDF]

open access: yes, 2015
The influenza virus is responsible for hundreds of childhood deaths and costs the health care system millions of dollars each year (Hassan, Lewis, Davis, Gebremariam, and Dombkowski, 2009).
Leder, Lindsey
core  

Global Public Goods and Global Health [PDF]

open access: yes, 2012
The repair rate on electron beam welded diaphragm hasn’t been at the desired level at Siemens SIT for several years. An improvement program the past five years has reduce the repair rate from 60% to 12-15% but the goal of 5% repair rate hasn’t been met ...
Gartner, David
core   +1 more source

Exploring the Potential of T-Cells for a Universal Influenza Vaccine. [PDF]

open access: yesVaccines (Basel), 2020
Vijayanand S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy